| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Pantoprazole | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | apixaban | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | 4-Aminopyridine | FAERS: 2 | US FAERS | |
| 4 | Dabigatran | FAERS: 2 | US FAERS | |
| 5 | Sorafenib | FAERS: 2 | US FAERS | |
| 6 | etonogestrel | FAERS: 2 | US FAERS | |
| 7 | regorafenib | FAERS: 2 | US FAERS | |
| 8 | Norgestrel | FAERS: 1 | US FAERS | |
| 9 | Phenylephrine | FAERS: 1 | US FAERS | |
| 10 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 11 | dofetilide | FAERS: 1 | US FAERS | |
| 12 | macitentan | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.